| FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma DH Kim, HD Jung, JG Kim, JJ Lee, DH Yang, YH Park, YR Do, HJ Shin, ... Blood 108 (8), 2720-2725, 2006 | 236 | 2006 |
| Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia DHD Kim, L Sriharsha, W Xu, S Kamel-Reid, X Liu, K Siminovitch, ... Clinical cancer research 15 (14), 4750-4758, 2009 | 217 | 2009 |
| Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia DH Kim, S Kamel-Reid, H Chang, R Sutherland, CW Jung, HJ Kim, JJ Lee, ... Haematologica 94 (1), 135-139, 2009 | 176 | 2009 |
| Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia DY Kim, YD Joo, SN Lim, SD Kim, JH Lee, JH Lee, DHD Kim, K Kim, ... Blood 126 (6), 746-756, 2015 | 175 | 2015 |
| Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance D Siegal, A Keller, W Xu, S Bhuta, DH Kim, J Kuruvilla, JH Lipton, ... Biology of Blood and Marrow Transplantation 13 (11), 1369-1379, 2007 | 165 | 2007 |
| Rapid helper T-cell recovery above 200× 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation DH Kim, SK Sohn, DI Won, NY Lee, JS Suh, KB Lee Bone marrow transplantation 37 (12), 1119-1128, 2006 | 146 | 2006 |
| Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma DH Kim, JH Baek, YS Chae, YK Kim, HJ Kim, YH Park, HS Song, ... Leukemia 21 (10), 2227-2230, 2007 | 133 | 2007 |
| Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation KW Seo, DH Kim, SK Sohn, NY Lee, HH Chang, SW Kim, SB Jeon, ... Bone marrow transplantation 36 (12), 1089, 2005 | 131 | 2005 |
| Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia S Branford, DDH Kim, JF Apperley, CA Eide, S Mustjoki, ST Ong, ... Leukemia 33 (8), 1835-1850, 2019 | 130 | 2019 |
| Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation DH Kim, JG Kim, SK Sohn, WJ Sung, JS Suh, KS Lee, KB Lee British journal of haematology 125 (2), 217-224, 2004 | 129 | 2004 |
| Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy TH Kim, MS Tyndel, HJ Kim, JS Ahn, SH Choi, HJ Park, Y Kim, SY Kim, ... Blood, The Journal of the American Society of Hematology 129 (1), 38-47, 2017 | 116 | 2017 |
| Multidrug resistance‐1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia DH Kim, JY Park, SK Sohn, NY Lee, JH Baek, SB Jeon, JG Kim, JS Suh, ... International journal of cancer 118 (9), 2195-2201, 2006 | 111 | 2006 |
| Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphoma SK Sohn, JT Jung, DH Kim, JG Kim, EK Kwak, T Park, DG Shin, KR Sohn, ... American journal of hematology 73 (2), 101-107, 2003 | 110 | 2003 |
| Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse TH Kim, JH Moon, JS Ahn, YK Kim, SS Lee, SY Ahn, SH Jung, DH Yang, ... Blood, The Journal of the American Society of Hematology 132 (15), 1604-1613, 2018 | 100 | 2018 |
| Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia MH Chang, KH Kim, HS Kim, HJ Jun, DH Kim, JH Jang, K Kim, CW Jung European journal of haematology 84 (2), 154-159, 2010 | 100 | 2010 |
| Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients SJ Seong, M Lim, SK Sohn, JH Moon, SJ Oh, BS Kim, HM Ryoo, ... Annals of oncology 24 (3), 756-760, 2012 | 93 | 2012 |
| Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant JG Kim, SK Sohn, DH Kim, NY Lee, JS Suh, KS Lee, KB Lee European journal of haematology 73 (1), 56-61, 2004 | 92 | 2004 |
| Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with … J Gwang Kim, S Kyun Sohn, D Hwan Kim, JI Ho Baek, N Young Lee, ... Leukemia & lymphoma 46 (6), 885-891, 2005 | 87 | 2005 |
| Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts DH Kim, N Jamal, R Saragosa, D Loach, J Wright, V Gupta, J Kuruvilla, ... Biology of Blood and Marrow Transplantation 13 (10), 1233-1243, 2007 | 86 | 2007 |
| CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas JG Kim, SK Sohn, YS Chae, DH Kim, JH Baek, KB Lee, JJ Lee, IJ Chung, ... Cancer chemotherapy and pharmacology 58 (1), 35-39, 2006 | 81 | 2006 |
